Psoriasis is a chronic, recurring inflammatory skin disorder, which affects two-four percent of the total population, and it can cause a wide range of other diseases. It is well-documented that psoriasis affect the quality of life negatively and is associated with both depression and anxiety.
It is estimated that as much as 40% of psoriasis patients are not complying with their treatment. Patients in biological treatment are better at following the treatment, but studies show that they are not satisfied with it. Psoriasis patients come from the entire Region of Southern Denmark for regular outpatient consultations at Odense University Hospital every three months, which can be invasive in the everyday life of the individual patient.
The project is a qualitative study based on participatory design, which actively involves patients and health professionals in the design and development of the technological solution. The theoretical scope of the project is empowerment, which is intented to strengthen the patients’ own ressources.
The aim of this PhD project is, in collaboration with patients and health professionals, to design and develop a technological solution for psoriasis patients undergoing biological treatment. The solution aims to increase the quality of life and strengthen the patients’ empowerment and reduce inequality in health as a result of geographical distances.
The solution will ensure both security and quality in the treatment and at the same time reduce the inspection visits at the hospital.
Jane Clemensen Dorthe Boe Danbjørg
The project is financed by Novartis, Kirsten Wehnert and Robert Wehnerts Fund and the University of Southern Denmark, the OUH Innovation Fund and the Department of Dermatology and Allergy Centre at OUH.